Regeneron Pharmaceuticals
Patents, Design & Utilities
Last updated:
List of all Regeneron Pharmaceuticals patents 704 in total
| Status | Patent |
|---|---|
Grant | Utility: Anti-VEGF protein compositions and methods for producing the same Filling date: 12 Sep 2025 Issue date: 6 Jul 2021 |
Grant | Utility: Genetically modified mice and engraftment Filling date: 12 Sep 2025 Issue date: 6 Jul 2021 |
Grant | Utility: Mouse having an engineered immunoglobulin lambda light chain Filling date: 12 Sep 2025 Issue date: 6 Jul 2021 |
Grant | Utility: Methods for treating active eosinophilic esophagitis Filling date: 12 Sep 2025 Issue date: 6 Jul 2021 |
Application | Utility: GENETICALLY MODIFIED MAJOR HISTOCOMPATIBILITY COMPLEX MICE Filling date: 12 Sep 2025 Issue date: 1 Jul 2021 |
Application | Utility: NON-HUMAN ANIMALS EXPRESSING EXOGENOUS TERMINAL DEOXYNUCLEOTIDYLTRANSFERASE Filling date: 12 Sep 2025 Issue date: 1 Jul 2021 |
Application | Utility: ANTI-FACTOR XII/XIIa ANTIBODIES AND USES THEREOF Filling date: 12 Sep 2025 Issue date: 1 Jul 2021 |
Grant | Utility: Methods for de novo protein sequencing Filling date: 12 Sep 2025 Issue date: 29 Jun 2021 |
Application | Utility: Adenylate Cyclase 7 (ADCY7) Variants And Uses Thereof Filling date: 12 Sep 2025 Issue date: 24 Jun 2021 |
Application | Utility: NOVEL IL2 AGONISTS AND METHODS OF USE THEREOF Filling date: 12 Sep 2025 Issue date: 24 Jun 2021 |
Application | Utility: NOVEL IL2 AGONISTS AND METHODS OF USE THEREOF Filling date: 12 Sep 2025 Issue date: 24 Jun 2021 |
Application | Utility: Systems and Methods for Auto-Inoculation in Seed Train and Production Processes Filling date: 12 Sep 2025 Issue date: 17 Jun 2021 |
Application | Utility: METHODS OF ASSESSING ANTIBODY-DRUG CONJUGATES Filling date: 12 Sep 2025 Issue date: 10 Jun 2021 |
Application | Utility: NOVEL CHO INTEGRATION SITES AND USES THEREOF Filling date: 12 Sep 2025 Issue date: 10 Jun 2021 |
Application | Utility: ANTI-HEMAGGLUTININ ANTIBODIES AND METHODS OF USE THEREOF Filling date: 12 Sep 2025 Issue date: 10 Jun 2021 |
Application | Utility: ANTI-VEGF PROTEIN COMPOSITIONS AND METHODS FOR PRODUCING THE SAME Filling date: 12 Sep 2025 Issue date: 10 Jun 2021 |
Grant | Utility: Genetically modified non-human animals and methods of use thereof Filling date: 12 Sep 2025 Issue date: 8 Jun 2021 |
Grant | Utility: Mice expressing a limited immunoglobulin light chain repertoire Filling date: 12 Sep 2025 Issue date: 8 Jun 2021 |
Grant | Utility: Treatment of inflammatory conditions by delivery of interleukin-1 receptor antagonist fusion protein Filling date: 12 Sep 2025 Issue date: 8 Jun 2021 |
Application | Utility: MICE THAT MAKE VL BINDING PROTEINS Filling date: 12 Sep 2025 Issue date: 3 Jun 2021 |
Application | Utility: NON-HUMAN ANIMALS HAVING A HUMANIZED A PROLIFERATION-INDUCING LIGAND GENE Filling date: 12 Sep 2025 Issue date: 3 Jun 2021 |
Application | Utility: NON-HUMAN ANIMALS HAVING A HUMANIZED CLUSTER OF DIFFERENTIATION 47 GENE Filling date: 12 Sep 2025 Issue date: 3 Jun 2021 |
Application | Utility: Human Antibodies to S. Aureus Hemolysin A Toxin Filling date: 12 Sep 2025 Issue date: 3 Jun 2021 |
Application | Utility: HIGH AFFINITY HUMAN ANTIBODIES TO HUMAN IL-4 RECEPTOR Filling date: 12 Sep 2025 Issue date: 3 Jun 2021 |
Application | Utility: ANTI-ACTIVIN A ANTIBODIES AND USES THEREOF Filling date: 12 Sep 2025 Issue date: 3 Jun 2021 |
Grant | Utility: Non-human animals having a humanized signal-regulatory protein gene Filling date: 12 Sep 2025 Issue date: 1 Jun 2021 |
Grant | Utility: Humanized low affinity FC.gamma.R mouse cells Filling date: 12 Sep 2025 Issue date: 1 Jun 2021 |
Grant | Utility: Methods and compositions for assessing CRISPER/Cas-mediated disruption or excision and CRISPR/Cas-induced recombination with an exogenous donor nucleic acid in vivo Filling date: 12 Sep 2025 Issue date: 1 Jun 2021 |
Grant | Utility: Methods for quantitating individual antibodies from a mixture Filling date: 12 Sep 2025 Issue date: 1 Jun 2021 |
Application | Utility: SITE-SPECIFIC QUANTITATION OF DRUG CONJUGATIONS Filling date: 12 Sep 2025 Issue date: 27 May 2021 |
Grant | Utility: Humanized dipeptidyl-peptidase IV (DPP4) animals Filling date: 12 Sep 2025 Issue date: 25 May 2021 |
Application | Utility: DIAGNOSTIC TESTS AND METHODS FOR ASSESSING SAFETY, EFFICACY OR OUTCOME OF ALLERGEN-SPECIFIC IMMUNOTHERAPY (SIT) Filling date: 12 Sep 2025 Issue date: 20 May 2021 |
Application | Utility: BISPECIFIC ANTIGEN-BINDING MOLECULES THAT BIND A STAPHYLOCOCCUS TARGET ANTIGEN AND A COMPLEMENT COMPONENT AND USES THEREOF Filling date: 12 Sep 2025 Issue date: 20 May 2021 |
Application | Utility: ANTI-EGFRVIII ANTIBODIES AND USES THEREOF Filling date: 12 Sep 2025 Issue date: 20 May 2021 |
Application | Utility: ANTI-GITR ANTIBODIES AND USES THEREOF Filling date: 12 Sep 2025 Issue date: 20 May 2021 |
Application | Utility: ANTI-CD8 ANTIBODIES AND USES THEREOF Filling date: 12 Sep 2025 Issue date: 20 May 2021 |
Application | Utility: COMPOSITIONS AND METHODS FOR REDUCING BIOBURDEN IN CHROMATOGRAPHY Filling date: 12 Sep 2025 Issue date: 13 May 2021 |
Application | Utility: RADIOLABELED ANTI-LAG3 ANTIBODIES FOR IMMUNO-PET IMAGING Filling date: 12 Sep 2025 Issue date: 13 May 2021 |
Application | Utility: METHODS AND SYSTEMS FOR IDENTIFYING, CLASSIFYING, AND/OR RANKING GENETIC SEQUENCES Filling date: 12 Sep 2025 Issue date: 13 May 2021 |
Application | Utility: Accurate And Robust Information-Deconvolution From Bulk Tissue Transcriptomes Filling date: 12 Sep 2025 Issue date: 13 May 2021 |
Application | Utility: DOSING REGIMENS FOR TREATING OR PREVENTING C5-ASSOCIATED DISEASES Filling date: 12 Sep 2025 Issue date: 13 May 2021 |
Grant | Utility: Non-human animals having a humanized B-cell activating factor gene Filling date: 12 Sep 2025 Issue date: 11 May 2021 |
Application | Utility: GENETIC MODIFICATION OF RATS Filling date: 12 Sep 2025 Issue date: 6 May 2021 |
Application | Utility: N-TERMINAL scFv MULTISPECIFIC BINDING MOLECULES Filling date: 12 Sep 2025 Issue date: 6 May 2021 |
Application | Utility: COMBINATION THERAPY TO TREAT BRAIN CANCER Filling date: 12 Sep 2025 Issue date: 6 May 2021 |
Application | Utility: METHODS OF TREATING UREA CYCLE DISORDERS BY INTERFERING WITH GLUCAGON RECEPTOR SIGNALING Filling date: 12 Sep 2025 Issue date: 6 May 2021 |
Grant | Utility: Methods for inhibiting atherosclerosis by administering an anti-PCSK9 antibody Filling date: 12 Sep 2025 Issue date: 4 May 2021 |
Grant | Utility: Methods of treating severe insulin resistance by interfering with glucagon receptor signaling Filling date: 12 Sep 2025 Issue date: 4 May 2021 |
Application | Utility: USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS Filling date: 12 Sep 2025 Issue date: 29 Apr 2021 |
Grant | Utility: Genetically modified major histocompatibility complex mice Filling date: 12 Sep 2025 Issue date: 27 Apr 2021 |
Showing 150 to 200 of 704 patents.